COBRE Center on Opioids and Overdose

COBRE 阿片类药物和药物过量中心

基本信息

  • 批准号:
    10711725
  • 负责人:
  • 金额:
    $ 249.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-01 至 2028-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract We propose to further strengthen and sustain the successful Center of Biomedical Research Excellence (COBRE) on Opioids and Overdose at Rhode Island Hospital and affiliated research institutions. The motivation for this effort lies in the ongoing tremendous need for greater scientific understanding of the mechanisms underpinning vulnerability to opioid use and overdose and a need for more effective interventions to treat and prevent opioid misuse and overdose. We will approach these challenges through ongoing, cooperative partnership among senior scientists and early career investigators across several complementary disciplines. We will continue our unique and innovative mentoring strategy that, in addition to primary project advising, provides junior faculty members with specialized mentorship and services that empowers investigators to influence policy and practice through their research. Moreover, our four interdisciplinary cores provide infrastructure, consultation, and additional support services to ensure the successful career development of our Project Leaders. The long-term goal of the Center is to strengthen and sustain a critical mass of investigators specializing in opioids and overdose that benefits affected populations and enhances the competitiveness of affiliated investigators. The objective of this proposal is to strengthen and continue to develop the COBRE Center and to support the research activities of junior Project Leaders to ensure their transition to R01-funded scientists and enhance the critical mass of researchers. There are two Specific Aims—one related to the strengthening of our disease-specific research center, and one encompassing three Research Projects that are linked by the themes of opioids and overdose. Aim 1: Strengthen the cores needed to further develop and sustain our thematic multidisciplinary center of research excellence on opioids and overdose. Four cores will continue to strive to achieve this aim: our Administrative Core, Data and Research Methods Core, Translational and Transformative Core, and Community Engaged Research Core. Aim 2: Support the selection, mentorship, and career development of early career faculty Project Leaders. The three initial research projects are: Project 1: Nicole Weiss, PhD - Prediction of Return to Opioid Use During Immediate Community Reintegration, Project 2: Michael Bernstein, PhD- Optimizing Open Label Placebos for Chronic Pain Patients, and Project 3: new RPL to be assigned; R01 notice of award was received, effective 9/30/22, for originally planned researcher. The Center brings together an interdisciplinary group of accomplished senior scientists, promising junior investigators, and distinguished advisors and collaborators to work collectively to strengthen our center of excellence in an area of clinical research that is of critical public health importance.
项目概要/摘要 我们建议进一步加强和维持成功的生物医学研究卓越中心 (COBRE) 罗德岛医院及其附属研究机构的阿片类药物和过量用药。这 这项努力的动机在于对更深入地科学理解的持续巨大需求 阿片类药物使用和过量的脆弱性机制以及需要更有效的干预措施 治疗和预防阿片类药物滥用和过量。我们将通过持续的、 资深科学家和早期职业研究人员之间的合作伙伴关系跨越几个互补的领域 学科。我们将继续我们独特和创新的指导策略,除了主要项目之外 提供咨询,为初级教员提供专门的指导和服务,以增强他们的能力 调查人员通过他们的研究影响政策和实践。此外,我们的四个跨学科核心 提供基础设施、咨询和额外的支持服务,以确保成功的职业生涯 我们的项目负责人的发展。该中心的长期目标是加强和维持关键的 大量专门研究阿片类药物和过量用药的研究人员,这使受影响的人群受益并增强了 附属研究人员的竞争力。该提案的目的是加强并继续 发展 COBRE 中心并支持初级项目负责人的研究活动,以确保他们 向 R01 资助的科学家过渡并增强研究人员的临界质量。具体有两个 目标——一个与加强我们的特定疾病研究中心有关,一个包含三个 以阿片类药物和过量用药为主题的研究项目。目标1:强化核心 需要进一步发展和维持我们的专题多学科卓越研究中心 阿片类药物和过量。四个核心将继续努力实现这一目标:我们的管理核心、数据核心 和研究方法核心、转化和变革核心以及社区参与研究 核。目标 2:支持早期职业教师项目的选拔、指导和职业发展 领导们。三个初始研究项目是: 项目 1:Nicole Weiss 博士 - 预测阿片类药物回归 在立即重新融入社区期间使用,项目 2:Michael Bernstein 博士 - 优化开放标签 慢性疼痛患者的安慰剂,以及项目 3:分配新的 RPL; R01 中标通知书是 已收到,于 2022 年 9 月 30 日生效,适用于原计划的研究人员。该中心汇集了跨学科的 一群有成就的资深科学家、有前途的初级研究人员和杰出的顾问 合作者共同努力,加强我们在临床研究领域的卓越中心 至关重要的公共卫生重要性。

项目成果

期刊论文数量(215)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation.
  • DOI:
    10.1186/s12954-023-00741-w
  • 发表时间:
    2023-02-04
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Frueh, Lisa;Collins, Alexandra B. B.;Newman, Roxxanne;Barnett, Nancy P. P.;Rich, Josiah D. D.;Clark, Melissa A. A.;Marshall, Brandon D. L.;Macmadu, Alexandria
  • 通讯作者:
    Macmadu, Alexandria
Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19.
  • DOI:
    10.1007/s11606-021-07249-8
  • 发表时间:
    2022-04
  • 期刊:
  • 影响因子:
    5.7
  • 作者:
    Samuels EA;Khatri UG;Snyder H;Wightman RS;Tofighi B;Krawczyk N
  • 通讯作者:
    Krawczyk N
Racial and ethnic differences in emotion regulation: A systematic review.
情绪调节中的种族和种族差异:系统评价。
  • DOI:
    10.1002/jclp.23284
  • 发表时间:
    2022-05
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Weiss, Nicole H.;Thomas, Emmanuel D.;Schick, Melissa R.;Reyes, Miranda E.;Contractor, Ateka A.
  • 通讯作者:
    Contractor, Ateka A.
The differential relation of trauma types with negative and positive emotion dysregulation.
  • DOI:
    10.1080/10615806.2021.1964072
  • 发表时间:
    2022-07
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Berfield, Jillian B.;Goncharenko, Svetlana;Forkus, Shannon R.;Contractor, Ateka A.;Weiss, Nicole H.
  • 通讯作者:
    Weiss, Nicole H.
Psychometric Evaluation of the Posttrauma Risky Behaviors Questionnaire: Item Response Theory Analyses.
  • DOI:
    10.1177/10731911211036760
  • 发表时间:
    2022-12
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Natesan Batley, Prathiba;Contractor, Ateka A.;Weiss, Nicole H.;Compton, Sidonia E.;Price, Matthew
  • 通讯作者:
    Price, Matthew
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSIAH D RICH其他文献

JOSIAH D RICH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSIAH D RICH', 18)}}的其他基金

Evaluating the decriminalization of non-prescribed buprenorphine in Rhode Island
评估罗德岛州非处方丁丙诺啡的非刑事化
  • 批准号:
    10676209
  • 财政年份:
    2022
  • 资助金额:
    $ 249.86万
  • 项目类别:
Evaluating the decriminalization of non-prescribed buprenorphine in Rhode Island
评估罗德岛州非处方丁丙诺啡的非刑事化
  • 批准号:
    10549069
  • 财政年份:
    2022
  • 资助金额:
    $ 249.86万
  • 项目类别:
Evaluation of Low Threshold Buprenorphine Treatment in the Context of COVID-19
COVID-19 背景下低阈值丁丙诺啡治疗的评估
  • 批准号:
    10358229
  • 财政年份:
    2021
  • 资助金额:
    $ 249.86万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10711726
  • 财政年份:
    2018
  • 资助金额:
    $ 249.86万
  • 项目类别:
COBRE Center on Opioids and Overdose
COBRE 阿片类药物和药物过量中心
  • 批准号:
    10690931
  • 财政年份:
    2018
  • 资助金额:
    $ 249.86万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10256004
  • 财政年份:
    2018
  • 资助金额:
    $ 249.86万
  • 项目类别:
COBRE Center on Opioids and Overdose
COBRE 阿片类药物和药物过量中心
  • 批准号:
    10006576
  • 财政年份:
    2018
  • 资助金额:
    $ 249.86万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10006596
  • 财政年份:
    2018
  • 资助金额:
    $ 249.86万
  • 项目类别:
COBRE Center on Opioids and Overdose
COBRE 阿片类药物和药物过量中心
  • 批准号:
    9766319
  • 财政年份:
    2018
  • 资助金额:
    $ 249.86万
  • 项目类别:
COBRE Center on Opioids and Overdose
COBRE 阿片类药物和药物过量中心
  • 批准号:
    9415666
  • 财政年份:
    2018
  • 资助金额:
    $ 249.86万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 249.86万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 249.86万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 249.86万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 249.86万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 249.86万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 249.86万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 249.86万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 249.86万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 249.86万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 249.86万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了